Comparative study to investigate the effect of meloxicam or minocycline HCl in situ gel system on local treatment of periodontal pockets.
In situ gelling formulations allow easy application to the target area. Gelation is induced by physiological stimuli at the site of application where the formula attains semisolid properties and exerts sustained drug release. In situ gelling formulations containing either 3% meloxicam (Mx) or 2% minocycline HCl (MH) were prepared for local application into the periodontal pockets. Gel formulations were based on the thermosensitive Pluronic(®) (Pl) and the pH-sensitive Carbopol(®) (C) polymers. C gels were prepared in combination with HPMC (H) to decrease its acidity. The total percent drug released from Pl formulae was 21.72% after 1 week for Mx and 85% after 3 days for MH. Their release kinetics data indicated anomalous non-Fickian behavior that could be controlled by both diffusion and chain relaxation. Addition of MH to C/H gels (1:2.5) resulted in liquefaction, followed by drug precipitation. Regarding C/H gel containing Mx, it showed a prolonged release rate up to 7 days with an initial burst effect; the kinetics data revealed Fickian-diffusion mechanism. The in vitro antibacterial activity studies for MH gel in Pl revealed that the drug released exceeded the minimum inhibitory concentration (MIC) of MH against Staphylococcus aureus ATCC 6538; placebo gel showed no effect on the microorganism. Clinical evaluation of Pl gels containing either Mx or MH showed significant improvement in chronic periodontitis patients, manifested by decrease in pocket depth and gingival index and increase in bone density.
Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt, abeerkassem2002@gmail.com.
Abeer Ahmed
AA
Kassem
Fatma Ahmed
FA
Ismail
Vivian Fahim
VF
Naggar
Elsayed
E
Aboulmagd
D000328:Adult; D000900:Anti-Bacterial Agents / Q000737:chemistry / Q000494:pharmacology; D002626:Chemistry, Pharmaceutical / Q000379:methods; D003692:Delayed-Action Preparations / Q000737:chemistry / Q000494:pharmacology; D004058:Diffusion; D065546:Drug Liberation; D005260:Female; D005782:Gels / Q000737:chemistry* / Q000494:pharmacology*; D006801:Humans; D007700:Kinetics; D000077239:Meloxicam; D008911:Minocycline / Q000737:chemistry* / Q000494:pharmacology*; D010514:Periodontal Pocket / Q000188:drug therapy*; D011108:Polymers / Q000737:chemistry / Q000494:pharmacology; D013211:Staphylococcus aureus / Q000187:drug effects; D013843:Thiazines / Q000737:chemistry* / Q000494:pharmacology*; D013844:Thiazoles / Q000737:chemistry* / Q000494:pharmacology*; D055815:Young Adult
D000900:Anti-Bacterial Agents; D003692:Delayed-Action Preparations; D005782:Gels; D011108:Polymers; D013843:Thiazines; D013844:Thiazoles; D008911:Minocycline; D000077239:Meloxicam